Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
12/2008
12/10/2008EP1074564B1 Substance with antithrombotic activity and method for detecting glycokallidin
12/10/2008EP1042350B1 Inducible phosphofructokinase and the warburg effect
12/10/2008EP1021464B1 Cellular receptor for hiv-1 vpr essential for g2/m phase transition of the cell cycle
12/10/2008EP1005494B1 High avidity polyvalent and polyspecific reagents
12/10/2008EP0972054B1 Enhancement of immune response using targeting molecules
12/10/2008CN101321870A Recombinant human EPO-Fc fusion proteins with prolonged half-life and enhanced erythropoietic activity in vivo
12/10/2008CN101321784A Nanobodies and polypeptides against EGFR and IGF-IR
12/10/2008CN101321783A 人抗-b7rp1中和抗体 Human anti -b7rp1 neutralizing antibodies
12/10/2008CN101321782A Peptide inhibitors of ABL kinases
12/10/2008CN101321540A Interleukin-13 antibody composition
12/10/2008CN101319006A N terminal specific human Dbf4 polypeptide and antibody preparation method
12/10/2008CN101319005A C terminal specific human Dbf4 polypeptide and antibody preparation method
12/10/2008CN101319004A N terminal specific human YWHAE polypeptide and antibody preparation method
12/10/2008CN101319003A C terminal specific human YWHAE polypeptide and antibody preparation method
12/10/2008CN101319002A N terminal specific human MDC1 polypeptide and antibody preparation method
12/10/2008CN101319001A N terminal specific human DBF4B polypeptide and antibody preparation method
12/10/2008CN101319000A C terminal specific human TP53I3 polypeptide and antibody preparation method
12/10/2008CN101318999A N terminal specific human Eme1 polypeptide and antibody preparation method
12/10/2008CN101318998A C terminal specific human Eme1 polypeptide and antibody preparation method
12/10/2008CN101318997A C terminal specific human DNA mismatch repair protein MLH1 polypeptide and antibody preparation method
12/10/2008CN101318996A C terminal specific human BTRC polypeptide and antibody preparation method
12/10/2008CN101318019A Compositions and methods for the therapy of inflammatory bowel disease
12/10/2008CN101318018A Application of anti-aFGF-scFv in preparing antineoplastic medicament and preparation method thereof
12/10/2008CN100441689C EHEC 0157 shiga-like toxin IIA resisting subunit monoclonal antibody 5F3 light and heavy chain variable region gene and its application
12/10/2008CN100441688C Lim mineralization protein splice variants
12/10/2008CN100441597C Monoclonal antibody against influenza B virus and immunoassay instrument using the antibody
12/09/2008US7462705 Nucleic acids encoding an enediyne polyketide synthase complex
12/09/2008US7462704 use of RL9/RL10 protein and the polynucleotides encoding RL9/RL10 protein, e.g., in diagnosing and treating tumor, as well as the pharmaceutical composition containing RL9/RL10 protein or the antibody against it
12/09/2008US7462700 Vectors and host cells encoding and expressing canine RANKL polypeptide are provided, as well as antibodies that bind to RANKL and that inhibit RANKL activity
12/09/2008US7462699 Using presence of 60 amino acid botulinum polypeptide as evaluative tool in monitoring and prediciting efficacy of treatment protocols for treatment of clostridial infection
12/09/2008US7462698 Anti-CD26 antibodies and methods of use thereof
12/09/2008US7462696 Human antibodies that have MN binding and cell adhesion-neutralizing activity
12/09/2008US7462692 vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides
12/09/2008US7462691 Prostate stem cell antigen (PSCA) tumor antigen for use in diagnosis, prevention and treatment of prostate cancers
12/09/2008US7462597 Corticotropin releasing factor 2 receptor agonists
12/09/2008US7462486 Monitoring the efficacy of a T Cell Receptor (TCR) Variable peptide for the treatment of autoimmune diseases such as multiple sclerosis, Rheumatoid arthritis, systemic lupus erythematosis, type I diabetes, non-obese diabetes, psoriasis
12/09/2008US7462466 Porcine CD59 nucleic acids and cells containing the same
12/09/2008US7462465 Nucleic acid encoding KCNB potassium channel
12/09/2008US7462462 Peptide capable of binding to nanographite structures
12/09/2008US7462357 Polypeptide containing antigen segment; mixture with antibodies; immunostimulants
12/09/2008US7462353 administration of a function blocking antibody which is capable of binding an epitope of VLA-1; arthritis
12/09/2008US7462352 Methods of treatng B-cell diseases using humanized anti-CD19 antibodies
12/09/2008US7462350 cytokine fusion proteins with an increased therapeutic index; able to bind to more than one type of cytokine receptor expressed on cells
12/09/2008CA2037105C Diagnostic assay for alzheimer's disease
12/05/2008CA2631453A1 Glycoconjugates and their use as vaccine against shigella flexneri serotype 3a and x
12/05/2008CA2591253A1 Specific oligosaccharides of shigella flexneri serotypes 3a and x, their synthesis, compositions comprising them and their uses thereof
12/04/2008WO2008147883A1 Prevention and treatment of complement-associated eye conditions
12/04/2008WO2008147865A1 Point of care cervical screening system
12/04/2008WO2008147859A2 Self-assembled proteins and related methods and protein structures
12/04/2008WO2008147434A1 TREATMENT AND PREVENTION OF CHRONIC ASTHMA USING ANTAGONISTS OF INTEGRIN αVβ6
12/04/2008WO2008147196A2 Rsv-specific binding molecules and means for producing them
12/04/2008WO2008147143A2 Immunoglobulin fusion proteins
12/04/2008WO2008146911A1 Antibody directed against il13ra2, and diagnostic/therapeutic agent comprising the antibody
12/04/2008WO2008146854A1 Paratope and epitope of anti-mortalin antibody
12/04/2008WO2008146797A1 NOVEL GPIIIa GENE
12/04/2008WO2008146165A2 Kit of parts for the treatment of cancer or infectious diseases
12/04/2008WO2008146164A2 Streptococcus pneumoniae pilus antigens
12/04/2008WO2008146133A2 Hematopoietic cells that express mosc-1
12/04/2008WO2008146101A1 Ligands of hvem for treating hematologic malignancies and autoimmune diseases
12/04/2008WO2008145754A2 Ligands of hvem for treating hematologic malignancies and autoimmune diseases
12/04/2008WO2008145664A1 New indications for anti- il-i-beta therapy
12/04/2008WO2008145351A1 Immunoglobulin purification
12/04/2008WO2008145338A2 Monoclonal antibodies against claudin-18 for treatment of cancer
12/04/2008WO2008145142A1 Stable igg4 antibodies
12/04/2008WO2008145141A1 Method for extending the half-life of exogenous or endogenous soluble molecules
12/04/2008WO2008145140A2 Transgenic animals producing monovalent human antibodies and antibodies obtainable from these animals
12/04/2008WO2008145139A1 Fusion or linked proteins with extended half life
12/04/2008WO2008145138A1 Recombinant fucose modified monovalent half-antibodies obtained by molecular engineering
12/04/2008WO2008145137A2 Recombinant non glycosylated monovalent half-antibodies obtained by molecular engineering
12/04/2008WO2008145133A2 Method for manufacturing a recombinant polyclonal protein
12/04/2008WO2008144891A1 Humanized and chimeric anti-trop-2 antibodies that mediate cancer cell cytotoxicity
12/04/2008WO2008144890A1 Chimeric and humanized anti-cd44 antibodies that mediate cancer cell cytotoxicity
12/04/2008WO2008144889A1 Humanized and chimeric anti-cd59 antibodies that mediate cancer cell cytotoxicity
12/04/2008WO2008122551A3 Anti-epcam antibody and uses thereof
12/04/2008WO2008121615A3 Antibody formulation
12/04/2008WO2008120203A3 Antibodies and their uses for diagnosis and treatment of cytomegalovirus infection and associated diseases
12/04/2008WO2008118970A9 Constructs and libraries comprising antibody surrogate light chain sequences
12/04/2008WO2008106200A9 Human anti-ip-10 antibodies and uses thereof
12/04/2008WO2008104808A3 Compounds and methods for the modulation of beta-1 integrin function to mediate tissue repair
12/04/2008WO2008097582A3 Fluorescent single chain antibody (sc-fv) and its use in detection of analytes
12/04/2008WO2008091641A3 Compositions and methods for diagnosing and treating cancer
12/04/2008WO2008076560A9 Human monoclonal antibodies to btla and methods of use
12/04/2008WO2008073598A3 Methods for improving antibody production
12/04/2008WO2008070273A3 Methods of expressing lim mineralization protein
12/04/2008WO2008070083A3 Filter media using peptide-based antimicrobials
12/04/2008WO2008069999A3 Anti-p-selectin antibodies and methods of using the same to treat inflammatory diseases
12/04/2008WO2008063382A3 Antagonists of pcsk9
12/04/2008WO2008060645A3 Combinatorial therapy involving alpha5beta1 antagonists
12/04/2008WO2008057634A3 Polypeptides with enhanced anti-inflammatory and decreased cytotoxic properties and relating methods
12/04/2008WO2008043052A3 Human antibodies neutralizing human metapneumovirus
12/04/2008WO2008039761A3 Stabilized antibody formulations and uses thereof
12/04/2008WO2008035343A3 Artificial receptors
12/04/2008WO2008005429A3 Composition for modulating the expression of cell adhesion molecules
12/04/2008WO2007114959A3 Altered peptide ligands of gad65
12/04/2008WO2007092772A3 Protein formulations
12/04/2008WO2006124269A3 Human monoclonal antibodies that bind to very late antigen-1 for the treatment of inflammation and other disorders
12/04/2008US20080301826 Novel beta-actin and rps21 promoters and uses thereof
12/04/2008US20080301824 Parkin interacting polypeptides and methods of use
12/04/2008US20080300208 Isociatrate dehydrogenase and uses therof
12/04/2008US20080300207 Protein production
1 ... 472 473 474 475 476 477 478 479 480 481 482 483 484 485 486 487 488 489 490 491 492 ... 1494